AiCure is an Artificial Intelligence company that visually confirms medication ingestion. The patented mobile software-as-a-service (SaaS) platform is both scalable and flexible and can be adapted across diverse patient populations and therapeutic areas. Accurately measuring medication adherence is fundamental to both clinical trials and clinical care. Pharmaceutical companies, payers and providers benefit directly from accurate monitoring, improved adherence and optimized treatment models. Hundreds of billions of dollars are lost in failed trials and expensive hospitalizations because patient behavior is not well understood.  AiCure is opening up the possibilities of personalized medicine in new and exciting ways, allowing for insights into population health that have never been seen before as we connect patients to better treatment and improved health.

  • Initial Investment2015
  • SectorEnterprise
  • HeadquartersNew York, NY

Pritzker Group Home Page

Pritzker Group Venture Capital

Pritzker Group Private Capital

Pritzker Group Asset Management